TCL Archive Diet Supplements Should Be Held To Scientific Standards, Broder Tells House August 6, 1993
TCL Archive Phase II Study Meets Primary Endpoint, Demonstrating Overall Survival of 5.2 Months September 27, 2013
TCL Archive Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable January 31, 2003
TCL Archive In Brief: New Greg For Surgery Research Approved; Only 30 Bioassay Program Reports Still In Backlog April 21, 1978
